Major Bleeding Risk in Atrial Fibrillation Patients Co-Medicated With Non-Vitamin K Oral Anticoagulants and Antipsychotics

• Egile Nagusiak: Chiung-Mei Chen (Egilea), Kuo-Hsuan Chang (Egilea), Chun-Li Wang (Egilea), Hui-Tzu Tu (Egilea), Yu-Tung Huang (Egilea), Hsiu-Chuan Wu (Egilea), Chien-Hung Chang (Egilea), Shang-Hung Chang (Egilea)
• Formatua: Liburua
• Argitaratua: Frontiers Media S.A., 2022-04-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Major bleeding risks associated with non-vitamin K oral anticoagulants (NOACs) used with and without concurrent antipsychotics in patients with non-valvular atrial fibrillation (AF) were assessed. A total of 98,863 patients with non-valvular AF receiving at least one NOAC prescription from Taiwan�...